Fig. 3

Selection of candidate signature for Pompe disease: (a) tuning feature screening in the LASSO model; (b) the accuracy and error rate of curve changes after 10x cross validation via the SVM-RFE arithmetic; (c) Venn graph displaying 3 signature genes shared by LASSO and SVM-RFE.